DUBLIN--(BUSINESS WIRE)--Sep. 4, 2013--
(NYSE: COV), a leading global provider of healthcare products, today
announced the agenda for its investor meeting on Thursday, September 12,
2013. The event will be held at Cipriani, 55 Wall Street, New York, NY.
A webcast of the presentations will begin at approximately 2:20 pm ET
and will conclude by 5:00 pm ET.
The program will begin with rotational sessions where attendees will
visit Covidien's product displays, hear from industry experts discussing
how Covidien technology is being used and learn about the Company’s
early stage growth opportunities. Following these sessions will be
formal presentations by Covidien's Chairman, President and Chief
Executive Officer José (Joe) E. Almeida and other Covidien leaders, as
well as Q&A with members of the senior management team.
For those investors who are unable to attend the meeting in person, but
would like to ask a question of the management team during the meeting,
questions can be emailed to firstname.lastname@example.org.
9:30 a.m. Registration Opens
10:00 a.m. – 2:15 p.m. Rotational
Product Displays; Senior Management interaction
Clinical Perspectives on Covidien Technology
Covidien’s Early Stage Growth Opportunities
2:20 p.m. Senior Management Presentations
José (Joe) E. Almeida, Chairman, President and CEO
Brian D. King, President, Emerging Markets
Q&A with Senior Management Team
4:05 p.m. Charles J. Dockendorff, Chief Financial Officer
5:00 p.m. Presentations and webcast end
Advanced registration is required and attendance will be limited to
those who register in advance. To register for the meeting, please go to
the following website: http://survey.covidien.com/f/537189/1e8a/.
Individuals who are unable to attend the meeting in person will be able
to view a live video and webcast at Covidien’s website: http://investor.covidien.com.
A replay of the presentations and the presentation materials will be
available at the same website following the conclusion of the meeting.
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien manufactures,
distributes and services a diverse range of industry-leading products in
medical devices and supplies. With 2012 revenue of $9.9 billion,
Covidien has 38,000 employees worldwide in 70 countries, and its
products are sold in over 140 countries. Please visit www.covidien.com
to learn more about our business.
Jacqueline Strayer, 508-261-8305
Senior Vice President
Lannum, CFA, 508-452-4343